Difficult-To-Purify And Difficult-To-Filter Small Molecules: A Framework For Downstream Process Development

A promising API can be synthesized efficiently and still fail commercially if it cannot be purified economically or isolated in a form suited to large-scale manufacturing. PROTACs, ADC linker-payloads, and highly functionalized APIs make that risk more common. The authors, Bertram Cezanne, Axel Becker, and Benjamine Hale, argue that filtration and purification problems share molecular origins and are best addressed together. The paper examines why crystallization is more than an isolation step, what changes when chromatography enters the process, and how fraction mapping and predictive modeling shape scale-up decisions. It also weighs the tradeoffs among yield, purity, particle properties, and process economics.
Access the full white paper to see how these decisions fit together in a single development strategy.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.